Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Corry

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Gut|April 28, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancerShania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, et al.
Nature|November 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistanceMark White, Megan L Mills, Laura M Millett, et al.
Nature Genetics|June 3, 2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancerSudhir B Malla, Ryan M Byrne, Maxime W Lafarge, et al.
Nature Genetics|February 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancerSudhir B Malla, Ryan M Byrne, Maxime W Lafarge, et al.
Cell Reports|October 8, 2021
Role of miR-2392 in driving SARS-CoV-2 infectionJ Tyson McDonald, Francisco J Enguita, Deanne Taylor, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
The Great Deceiver: miR-2392's Hidden Role in Driving SARS-CoV-2 InfectionJ Tyson McDonald, Francisco Javier Enguita, Deanne Taylor, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Gut|April 28, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancerShania M Corry, Amy Mb McCorry, Tamsin Rm Lannagan, et al.
Nature|November 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistanceMark White, Megan L Mills, Laura M Millett, et al.
Nature Genetics|June 3, 2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancerSudhir B Malla, Ryan M Byrne, Maxime W Lafarge, et al.
Nature Genetics|February 14, 2024
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancerSudhir B Malla, Ryan M Byrne, Maxime W Lafarge, et al.
Cell Reports|October 8, 2021
Role of miR-2392 in driving SARS-CoV-2 infectionJ Tyson McDonald, Francisco J Enguita, Deanne Taylor, et al.
Biorxiv : the Preprint Server for Biology|May 5, 2021
The Great Deceiver: miR-2392's Hidden Role in Driving SARS-CoV-2 InfectionJ Tyson McDonald, Francisco Javier Enguita, Deanne Taylor, et al.
Pageof 16